PLASTIC AND RECONSTRUCTIVE SURGERY, cilt.137, sa.1, ss.109-113, 2016 (SCI-Expanded)
Background: Early degradation is a common complaint for hyaluronic acid fillers. Although the combination of hyaluronic acid fillers with botulinum neurotoxin type A presented improved clinical results, objective measurement of hyaluronic acid volumes has not been previously assessed.